O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.
about
O6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patientsGenomic analysis of diffuse intrinsic pontine gliomas identifies three molecular subgroups and recurrent activating ACVR1 mutationsAnalysis of an alternative human CD133 promoter reveals the implication of Ras/ERK pathway in tumor stem-like hallmarks.Comprehensive analysis of MGMT promoter methylation: correlation with MGMT expression and clinical response in GBMHigh epiregulin expression in human U87 glioma cells relies on IRE1α and promotes autocrine growth through EGF receptor.Comprehensive Glycomics of a Multistep Human Brain Tumor Model Reveals Specific Glycosylation Patterns Related to MalignancyNonsteroidal anti-inflammatory drug-activated gene (NAG-1/GDF15) expression is increased by the histone deacetylase inhibitor trichostatin AValproic acid for the treatment of malignant gliomas: review of the preclinical rationale and published clinical results.Progression of O⁶-methylguanine-DNA methyltransferase and temozolomide resistance in cancer research.Establishment and characterization of a new conditionally immortalized human astrocyte cell line.Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.The role of CXCR3/LRP1 cross-talk in the invasion of primary brain tumors.Immunohistochemical molecular gene expression profile of metastatic brain tumor as a potent personalized medicine.Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.O-6-methylguanine-DNA methyltransferase (MGMT) immunohistochemical expression in pituitary corticotroph adenomas.
P2860
Q24607903-5C9179D0-3B83-40F8-B34C-46CE5B29B5EFQ28237528-FBB49785-D610-4D49-8DD2-47351C5BEBF3Q33718376-E096DBA8-F18C-4E3F-ACF7-604A4A461538Q33797741-085BB2B1-616C-42F1-A05C-A8615C2EF391Q35065342-C9F9230E-38BF-4C21-94C7-214AA21AC71BQ35679876-37BF3354-9B4C-47EB-883D-4E52F32B97A3Q36981029-4F945DD2-3F03-4AB4-A1A2-1B61B554598BQ38016227-6B52DD13-FAC1-4128-8FE7-2E2C4F10FDF8Q38225830-AD9C04FD-69E9-4485-8892-427C511F9F9AQ38835686-306726A2-6989-4F0F-891A-9EF5B88388CCQ39908793-E9A8F153-0985-4AAC-BD01-23480EEDA69AQ44449800-7E1CC592-5CAF-4895-BB53-C3DC0317DD4DQ48280706-76CD13ED-CC12-4A07-B6F7-34FC6C6E3839Q55365652-732DFFD7-ED18-4C4E-A5F7-79254810023FQ55462926-A5B1D47C-202A-425A-B396-BF431975EAE2
P2860
O6-methylguanine-DNA methyltransferase is downregulated in transformed astrocyte cells: implications for anti-glioma therapies.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@ast
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@en
type
label
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@ast
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@en
prefLabel
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@ast
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@en
P2093
P2860
P356
P1433
P1476
O6-methylguanine-DNA methyltra ...... ons for anti-glioma therapies.
@en
P2093
Eiko Aoyanagi
Kouichi Tabu
Sadao Kaneko
Shinya Tanaka
Tsuyoshi Akagi
P2860
P2888
P356
10.1186/1476-4598-6-36
P577
2007-06-05T00:00:00Z
P5875
P6179
1021502155